PERNIX THERAPEUTICS HLDGS IN's ticker is and the CUSIP is 71426VAK4. A total of 14 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $10,000 | -96.0% | 2,000,000 | 0.0% | 0.00% | -96.2% |
| Q4 2018 | $250,000 | -70.2% | 2,000,000 | 0.0% | 0.05% | -67.5% |
| Q3 2018 | $840,000 | -4.5% | 2,000,000 | 0.0% | 0.16% | -6.9% |
| Q2 2018 | $880,000 | +10.0% | 2,000,000 | 0.0% | 0.18% | +4.8% |
| Q1 2018 | $800,000 | 0.0% | 2,000,000 | 0.0% | 0.17% | -3.5% |
| Q4 2017 | $800,000 | 0.0% | 2,000,000 | 0.0% | 0.17% | -3.4% |
| Q3 2017 | $800,000 | +60.0% | 2,000,000 | 0.0% | 0.18% | +57.0% |
| Q2 2017 | $500,000 | 0.0% | 2,000,000 | 0.0% | 0.11% | -5.0% |
| Q1 2017 | $500,000 | – | 2,000,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 22,760,000 | $6,745,000 | 1.39% |
| Telemetry Investments, L.L.C. | 9,000,000 | $1,530,000 | 0.69% |
| Broadfin Capital, LLC | 15,500,000 | $4,049,000 | 0.49% |
| Avoro Capital Advisors LLC | 6,000,000 | $1,651,000 | 0.21% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 51,775,000 | $14,238,000 | 0.21% |
| Aisling Capital LLC | 2,500,000 | $688,000 | 0.12% |
| Bruce & Co., Inc. | 2,000,000 | $500,000 | 0.12% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 2,000,000 | $582,000 | 0.06% |
| BARINGS LLC | 15,000,000 | $2,550,000 | 0.03% |
| ZAZOVE ASSOCIATES LLC | 2,000,000 | $550,000 | 0.03% |